Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
IgMin Publications Inc., Suite 102, West Hartford, CT - 06110, USA
Our mission centers on fostering scientific dialogue that accelerates the pace of discovery.
Biography
Qualified to practice the profession of doctor-surgeon in the autumn 1994 session
From 20 \ 5 \ 00 TO 17 \ 09 \ 01 service at the U.O. of Radiotherapy of Cosenza as a level I manager (fixed-term assignment)
From 17.09.01 it is in service at the U.O. of Radiotherapy of Cosenza as a level I manager indefinitely. (see suitability assessment of the head of radiation therapy)
He has been in charge of a highly specialized professional role since 21/9/06: External beam radiation therapy and interventional radiation therapy
Resolution N ° 727 of 09/21/2006 Hospital of Cosenza
Among the medical managers serving at the U.O. of belonging with greater seniority of highly specialized professional assignment.
Therefore from January 2008 he started the conformational radiotherapy treatments at the U.O. of belonging
From 29/09/2008 holder of qualification as Director of Complex Structure of Oncological Radiotherapy Resolution N ° 272 of 14/03/2008 Azienda Ospedaliera Di Cosenza
From 12/05/2009 to 31/12/2012 he held the position of substitute director of the structure
Since 01.01.2010 he is the holder of the highly specialized professional task of: Interventional Radiotherapy renewed on 01.01.2013
Resolution N ° 1268 of 30/12/2009 Hospital of Cosenza
Resolution N ° 522 of 05/16/2013 Cosenza Hospital
Since 15/04/2015 he has been in charge of the highly specialized professional task of: Brachytherapy treatments renewed on 01/01/2016
Resolution N ° 315 of 04/15/2015 Hospital of Cosenza
Resolution N ° 121 of 16/02/2016 Cosenza Hospital
Resolution N ° 97 of 29/01/2019 Hospital of Cosenza
Since 21.09.2011 he has been the referent for gynecological pathology within the PDTA called the Diagnostic Therapeutic Assistance Pathology for Female Cancer of the Cosenza Hospital. But he also attended meetings of the breast team by replacing and helping the PDTA manager
Since 16 July 2013, he has been the contact person for liver metastases within the PDTA called the Multidisciplinary Team of the patient with liver metastases of the Cosenza Hospital
Since 26 September 2017, he has been the contact person for lung disease in the PDTA called the Diagnostic Therapeutic Assistance Pathway for Lung Cancer of the Cosenza Hospital.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
byFabrizio Piro, Daria Cosentino, Ugo Piro, Gabriella Tocci and Luigi Marafioti
Background: Rectal toxicity is an important side effect of prostate cancer irradiation affecting 25% of patients. The role of dosimetric variables has a set of dose-volume constraints and curves to estimate the risk of rectal damage. The rectum position at the time of CT planning is different from the position during radiotherapy. Three methods are available to achieve optimal rectum position: enema; prostate cancer spacer; fiber-/fat-free diet. Methods: A 70.2 Gray radiation divided into 26 hypo-fractions was administered to 115 patients ...with prostate cancer by VMAT referred to a single center in Italy. To empty the rectum, all patients were administered a fiber-/fat-free diet and those with Eating Disorders (ED) were also added with activated charcoal (2 tablets/day) and a macrogol-based medical device (2 sachets/day). During treatment, the volumetric amount of rectum in the target was measured by comparing control-CT with simulation-CT, and acute toxicity was also checked. Results: The rectum position during control-CT in diet-only patients (29) predicted toxicity recorded during treatment, while in the ED group rectum position was adherent to position during simulations. Rectal volume target > 0.25 cc receiving a dose > V70 caused acute G3 toxicity that attenuated or worsened with rectal displacement. Acute rectal toxicity occurred in 6/29 (20.68%) patients (1 G3, 5 G1) in the diet-only group, while only in 1/86 (1.16%) patients (G1) in the ED group. No chronic toxicity was recorded in either group. Conclusion: Prostate cancer patients treated with VMAT, diet, charcoal, and macrogol emptied the rectum optimally and reduced incidence and severity of acute rectal toxicity, also with benefit on late toxicity.
